José Ballarín

The MEST score provides earlier risk prediction in lgA nephropathy

Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich et al. · Kidney International · 2015 · 289 citations · Full text

Medicine, Internal Medicine, Nephrology +10

Clinical Utility of Genetic Testing in Children and Adults with Steroid-Resistant Nephrotic Syndrome

Gemma Bullich, Bárbara Tazón‐Vega, Rafael García‐Maset et al. · Clinical Journal of the American Society of Nephrology · 2011 · 241 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Rachel Jones, Thomas F. Hiemstra, José Ballarín et al. · Annals of the Rheumatic Diseases · 2019 · 228 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy

Mario Espinosa, Rosa Ortega, Marina Sánchez et al. · Clinical Journal of the American Society of Nephrology · 2014 · 213 citations

Medicine, Nephrology, Pathology +17